Advancing Translational Drug Discovery

SAGE Labs Inc. and InterVivo Solutions, Inc. Jointly Announce their Partnership to Provide Research Services with Genetically Modified Rats

SAGE Labs Inc., a leading provider of in vivo products, services and technologies in the field of genome engineering, and InterVivo Solutions Inc., a leading provider of translational research services to improve clinical success of new drugs, jointly announced their partnership where SAGE Labs produces genetically engineered and validated animal models and InterVivo provides in-life and bioanalytical services.

All News Items